Download the free e-book on peptides, hormones and pharmaceuticals for longevity, health and performance here: get the e-book
There is a shift happening in how the medical and scientific community thinks about skeletal muscle. For most of medicine’s history, muscle has been viewed primarily as a mechanical tissue — the stuff that moves bones and allows physical function. Its metabolic and endocrine roles were understood as secondary, relevant mainly to athletes and people interested in body composition.
That view is changing rapidly and the change has significant implications for how anyone serious about longevity and optimization should think about their training.
Skeletal muscle is now understood to be the largest endocrine organ in the body, producing signaling molecules that communicate with the brain, the liver, the pancreas, the immune system, the gut, and adipose tissue. It is the primary site of glucose disposal, the primary driver of resting metabolic rate, a critical reservoir of amino acids for immune function and tissue repair, and a direct determinant of insulin sensitivity. Its preservation with age is one of the strongest predictors of healthspan and lifespan available in clinical medicine.
Understanding why muscle matters this much, what threatens it, and how to protect it is not a conversation for athletes. It is a conversation for anyone who wants to function well as they age.
What sarcopenia actually is and why it matters
Sarcopenia is the progressive, age-related loss of skeletal muscle mass and function. It begins in the early thirties in people who are not actively resisting it and accelerates significantly after fifty. The average person loses three to eight percent of muscle mass per decade in midlife and the rate of loss increases further in later life.
The consequences extend well beyond physical weakness and reduced athletic performance. Sarcopenia is independently associated with increased all-cause mortality, increased cardiovascular disease risk, increased metabolic syndrome risk, increased insulin resistance, impaired immune function, slower recovery from illness and injury, and reduced quality of life across virtually every dimension that medicine tracks.
The metabolic consequences are particularly significant and particularly underappreciated. As muscle mass declines, resting metabolic rate falls because muscle is the primary metabolically active tissue driving basal energy expenditure. The same caloric intake that was weight-neutral at thirty produces weight gain at fifty not primarily because metabolism has fundamentally broken but because the metabolically active tissue that was consuming those calories has declined. The body composition shift toward higher fat and lower muscle that characterizes aging is in large part a consequence of sarcopenia driving the metabolic rate downward while caloric intake stays roughly constant.
The insulin sensitivity consequence is equally consequential. Skeletal muscle is responsible for approximately eighty percent of insulin-stimulated glucose disposal. When you eat a meal and insulin rises in response, it is primarily muscle cells that clear the glucose from circulation. As muscle mass declines, this glucose disposal capacity declines, contributing directly to insulin resistance that is as much a consequence of lost muscle as it is of dietary patterns or visceral fat accumulation.
Why muscle is an endocrine organ
The reframing of skeletal muscle as an endocrine organ rests on the discovery of myokines — signaling proteins produced by muscle cells during contraction that travel through the bloodstream and produce biological effects in distant tissues.
The most studied and most important myokine is IL-6, which when produced by contracting muscle rather than by fat tissue has anti-inflammatory rather than pro-inflammatory effects. Exercise-induced muscle IL-6 drives fat oxidation, improves insulin sensitivity, and suppresses the pro-inflammatory cytokines that chronically elevated fat-tissue IL-6 produces. This is one of the mechanisms through which resistance training has systemic anti-inflammatory effects that extend well beyond the muscle itself.
Irisin is a myokine that promotes the conversion of white adipose tissue toward a more metabolically active beige adipose phenotype, increasing energy expenditure in fat tissue. It also promotes neuroplasticity through BDNF upregulation in the brain, connecting muscle contraction directly to cognitive health through a circulating signal.
BDNF itself is produced by contracting muscle cells and crosses the blood-brain barrier, where it supports hippocampal neurogenesis, synaptic plasticity, and the cognitive resilience that declines with inactivity and age. The cognitive benefits of exercise are not mediated purely by cardiovascular improvements — they are partly mediated by muscle-derived BDNF acting directly on brain tissue.
Myostatin is a muscle-produced protein that inhibits muscle growth, acting as a biological brake on hypertrophy. Its levels tend to rise with age and inactivity and fall in response to resistance training. Several compounds in the optimization catalogue including certain peptides have myostatin-modulating effects that support the muscle-building response to training.
The protein synthesis and mTOR picture
Muscle mass is determined by the balance between muscle protein synthesis and muscle protein breakdown. In youth, this balance favors synthesis. With age, the anabolic response to both protein ingestion and resistance training becomes blunted — a phenomenon called anabolic resistance — meaning older muscle needs more stimulus and more protein to produce the same synthetic response that younger muscle produces effortlessly.
The mTOR pathway, the primary driver of muscle protein synthesis in response to protein ingestion and resistance exercise, becomes less sensitive with age. Leucine, the amino acid most responsible for activating mTOR and driving the anabolic response to protein intake, needs to be present in higher amounts in older muscle to produce the same mTOR activation that lower amounts produce in younger muscle.
The practical implications of anabolic resistance are significant for anyone over forty pursuing muscle preservation or growth. Higher protein intake, not lower, is required to overcome blunted mTOR sensitivity. Higher training volumes and intensities are required to produce adequate mechanical stimulus. And the recovery window between training sessions may need to be longer as the repair process that follows muscle protein breakdown becomes slower.
Growth hormone, IGF-1, and the anabolic environment
The hormonal environment in which muscle protein synthesis occurs is as important as the training and nutrition stimulus that initiates it. Growth hormone and IGF-1 are the primary hormonal drivers of muscle anabolic capacity beyond testosterone, and their decline with age is one of the most direct contributors to anabolic resistance and the blunted muscle growth response in older individuals.
Growth hormone promotes muscle protein synthesis directly and through IGF-1, the downstream mediator of many of its anabolic effects. It also promotes fat oxidation and supports the body composition partition toward lean mass during periods of caloric restriction, protecting muscle during cuts in a way that low growth hormone environments cannot.
The growth hormone peptides in the catalogue, CJC-1295/Ipamorelin and Sermorelin, address the age-related decline in GH pulsatility directly. By restoring the amplitude and frequency of the overnight GH pulse, they support the anabolic environment that muscle preservation and growth depend on. Serial IGF-1 measurement tracks the response and confirms the GH axis is responding to the protocol.
BPC-157 and TB-500 in the muscle and connective tissue context
The recovery peptides address the repair side of the muscle equation. Resistance training produces controlled muscle damage that is repaired and rebuilt stronger, but the connective tissue that supports muscle function — tendons, ligaments, and the fascia that surrounds and connects muscle groups — does not repair as readily as muscle tissue and becomes a limiting factor in training capacity as it ages.
BPC-157’s angiogenic effects in connective tissue address the limited blood supply that makes tendons and ligaments so slow to heal. TB-500’s promotion of cellular migration supports the systemic repair response that the connective tissue repair process depends on. Together they support the training capacity that progressive overload requires by keeping the connective tissue infrastructure capable of handling the demands that meaningful training places on it.
The Wolverine and Klow combination stacks are the most comprehensive single-vial options for this application, addressing angiogenesis, cellular migration, anti-inflammatory resolution, and tissue remodeling simultaneously in ways that support both training recovery and the quality of healed connective tissue over time.
GLP-1 compounds and lean mass preservation
The body composition chapter of this publication has covered GLP-1 receptor agonists extensively for their fat loss effects. Their relationship with lean mass warrants specific attention in the muscle as medicine context.
The concern with significant caloric deficit and rapid weight loss is that lean mass is lost alongside fat mass. Research on GLP-1 compounds shows that the proportion of weight lost as fat versus lean mass is more favorable than with caloric restriction alone, but lean mass loss does occur and is a meaningful consideration in people with already limited muscle mass.
The optimization approach that produces the best body composition outcomes with GLP-1 therapy combines the caloric restriction and metabolic improvements of the GLP-1 with adequate protein intake to support muscle protein synthesis, resistance training to provide the mechanical stimulus that preserves and builds muscle despite the deficit, and growth hormone peptide support to maintain the anabolic hormonal environment during the weight loss phase.
This combination produces fat loss with lean mass preservation or even lean mass gain that neither GLP-1 therapy nor resistance training achieves as effectively alone.
The measurement picture
DEXA body composition scanning is the most accessible and most informative measurement tool for tracking the muscle as medicine picture over time. Appendicular lean mass index, the lean mass in the arms and legs relative to height, is the body composition metric most directly associated with the functional and longevity outcomes that sarcopenia research tracks. Serial DEXA measurement at six to twelve month intervals reveals whether lean mass is being preserved, gained, or lost in response to the protocol, providing the objective data that training feel and scale weight cannot.
Grip strength, measured with a hand dynamometer, is a surprisingly powerful predictor of all-cause mortality and functional capacity that is accessible and inexpensive. It is one of the most consistent predictors of sarcopenia severity and longevity outcomes in the epidemiological literature. Some optimization-focused practitioners track grip strength alongside DEXA as a functional correlate of the structural changes the scan measures.
The honest imperative
The muscle as medicine framing is not hyperbole. The evidence for skeletal muscle mass and function as a determinant of longevity, metabolic health, immune function, cognitive health, and quality of life is as strong as the evidence for any other single biological variable the optimization conversation addresses.
Building and preserving muscle is not a vanity project and it is not exclusively an athletic goal. It is one of the most direct investments available in the biological infrastructure that determines how well and how long you function. And it is the intervention that the optimization compounds in this catalogue are most directly designed to support — the training provides the stimulus, the protein provides the substrate, and the compounds provide the hormonal environment, the recovery capacity, and the repair infrastructure that make the whole system work.
This content is for educational purposes only and does not constitute medical advice. Always consult a licensed healthcare provider before making any changes to your health regimen. For more information visit www.peakformrx.health